FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets, Authority Hl7

31,787 resources

By Version

R2: 0
R2B: 0
R3: 645
R4: 19,478
R4B: 5,119
R5: 6,440
R6: 105

By Realm

none: 1,118
au: 63
be: 130
ca: 50
ch: 392
cl: 220
cr: 9
cz: 157
de: 50
dk: 18
ee: 30
eu: 391
fi: 4
fr: 70
it: 44
kr: 20
nl: 432
no: 6
nz: 9
pl: 70
pt: 3
se: 10
us: 12,201
uv: 16,286
other: 4

Start Prev Rows 1600 - 1800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Source(s)
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.40.json	C2S Opioids	active	2016-09	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.42.json	C2S Opioids	active	2016-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.43.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.44.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.45.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.46.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.47.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.48.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.49.json	C2S Sexuality and reproductive health information sensitivity	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.5.json	C2S Alcohol Use Disorders	active	2016-09	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.51.json	C2S Tobacco Use Disorders	active	2016-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.52.json	C2S Tobacco Use Disorders	active	2016-09	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.53.json	C2S Tobacco Use Disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.54.json	C2S Tobacco Use Disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.55.json	C2S Substance Use Information Sensitivity	active	2016-09	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.56.json	C2S Substance Use Information Sensitivity	active	2016-09	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.58.json	C2S Sensitive Categories	active	2016-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.59.json	C2S Opioids	active	2016-09	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.6.json	C2S Amphetamine Use Disorders	active	2016-09	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.60.json	C2S HIV/AIDS information Sensitivity	active	2016-09	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.65.json	Test C2S Alcohol Use Disorders	active	2019-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.67.json	Test C2S HIV/AIDS Information Sensitivity	active	2019-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.7.json	C2S Amphetamine Use Disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.8.json	C2S Amphetamine Use Disorders	active	2016-09	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1142.9.json	C2S Amphetamine Use Disorders	active	2016-09	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.10.json	Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1002.json	Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method)	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1012.json	S. Typhi Infection (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1016.json	S. Paratyphi Infection (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1017.json	S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1021.json	Dark Urine (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1022.json	Acute Onset [Qualifier Value] (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1024.json	Acute Viral Hepatitis (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1027.json	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM)	active	2023-06	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1029.json	Listeriosis [Listeria species] (Organism or Substance in Lab Results)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1030.json	Meningitis [Unspecified Cause] (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1032.json	Encephalitis [Unspecified Cause] (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1033.json	Encephalitis [Unspecified Cause] (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1035.json	Indeterminate or Equivocal Lab Result Value	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1037.json	Smoking Status [Current Nonsmoker] (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1040.json	Organisms (Tests by Unspecified Method)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1041.json	Organisms (Tests by Culture and Identification)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1044.json	Candida auris Infection (Tests for Candida auris by Culture and Identification Method)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1045.json	Candida auris Infection (Tests for Candida auris Nucleic Acid)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1047.json	Parkinson’s disease (Disorders) (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1048.json	Parkinson’s disease (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1049.json	Parkinsonism [Secondary] (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1050.json	Parkinsonism [Secondary] (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1065.json	Consciousness [Decreased Level] (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1071.json	Drug Use [IV Evidence] (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1072.json	Miosis (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1076.json	Opioid Overdose and Poisoning (Tests for Opioids [Quantitative])	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1083.json	Rash [Pustular Vesicular] (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1084.json	Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1090.json	Syphilis [Congenital] (Disorders) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1091.json	Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1092.json	Congenital heart disease (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1093.json	Hearing impairment (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1095.json	Microcephaly (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1096.json	Developmental delay (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1099.json	Congenital heart disease (ICD10CM)	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1100.json	Hearing impairment (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1104.json	Developmental delay (ICD10CM)	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1106.json	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.112.json	Tetanus (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1130.json	Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1131.json	Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1138.json	Staphylococcus Aureus (Tests by Culture and Identification Method)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1139.json	VISA/VRSA (Tests for Vancomycin Resistance Gene)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1145.json	Resistant Lab Result Value	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1148.json	Tests for Vancomycin Susceptibility [Ord]	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1149.json	Proteinuria (Tests for Total Protein in 24H Urine)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.115.json	Mumps (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1150.json	Thrombocytopenia (Tests for Platelets [#/volume] in Blood)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1156.json	Staphylococcus aureus (Organism or Substance in Lab Results)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1169.json	Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid)	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.117.json	Mumps (Disorders) (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1180.json	Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative])	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1186.json	Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative])	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1188.json	Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative])	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1196.json	Anthrax (Tests for Bacillus cereus by Culture and Identification Method)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1197.json	Cervical Lymphadenitis (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1207.json	CRE (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1212.json	Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1213.json	NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1214.json	Carbapenemase resistance mechanism (Organism or Substance in Lab Results)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1215.json	Tests for carbapenemase production	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1216.json	Tests for carbapenemase resistance mechanism	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1217.json	Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1218.json	Tests for carbapenem susceptibility [Ertapenem]	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1219.json	Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1220.json	NU_Tests for Enterobacteriaceae species by Culture and Identification Method	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1224.json	Therapeutic Response to Medication [Improved]	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1225.json	Altered Mental Status (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1230.json	Eschar (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1231.json	Hypotension (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1233.json	Localized Edema (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1234.json	Localized Edema (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1237.json	Tachycardia (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1238.json	Tachycardia (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1239.json	RCKMS Conditions (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.124.json	Poliomyelitis (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1240.json	Maternal Condition Puerperium (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1242.json	Non pestis Yersiniosis Infection (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1244.json	Blastomycosis (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1246.json	Blastomycosis (Organism or Substance in Lab Results)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1249.json	Blastomycosis (Tests for Blastomyces species by Culture and Identification Method)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1250.json	Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1251.json	Blastomycosis (Tests for Blastomyces species Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1252.json	Blastomycosis (Tests for Blastomyces species Antibody)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1253.json	Blastomycosis (Tests for Blastomyces species Antigen)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1265.json	Fatigue (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1269.json	Tuberculosis [Latent Infection] (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1274.json	Histoplasmosis (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1275.json	Histoplasmosis (Disorders) (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1281.json	Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1294.json	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1295.json	Seizure [Unspecified Cause] (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1298.json	Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)	active	2024-06	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1299.json	Seizure [Unspecified Cause] (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.130.json	Influenza (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1304.json	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1305.json	Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1306.json	Body Temperature (Vital Sign)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1307.json	Respiratory Rate (Vital Sign)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1309.json	RSV (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1310.json	RSV (Disorders) (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1312.json	RSV (Tests for RSV Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1314.json	Wheezing (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1317.json	Bronchiolitis (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1325.json	Tobacco Use and Exposure (Social History)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1330.json	Tobacco Smoking Status [Current] (Social History) (LOINC)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1335.json	Hospitalized [Inpatient] (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1336.json	Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1337.json	Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1340.json	Prion Disease (Tests for 14_3_3 Protein)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1341.json	Prion Disease (Tests for Abnormal Prion Protein)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1349.json	Cerebrospinal Fluid (Specimen Type) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.135.json	Chronic Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1350.json	Endocervical (Specimen Type) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1351.json	Tissue (Specimen Type) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1352.json	Specimen from a Normally Sterile Site (Specimen Type)(SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1353.json	Urethral Swab (Specimen Type) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1355.json	Wound (Specimen Type) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1359.json	Hepatitis E (Tests for hepatitis E virus IgM Antibody)	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.136.json	Invasive Pneumococcal Disease (Disorders) (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1360.json	Hepatitis E (Tests for hepatitis E virus Antibody)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1363.json	Epiglottitis (Disorders) (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1364.json	Organisms (Tests by Microscopic Observation by Gram Stain)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1369.json	Serum (Specimen Type) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1378.json	Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1379.json	Fish Poisoning (Disorders) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1388.json	Occupational Asthma (Disorders) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1389.json	Asthma (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1390.json	Asthma (Disorders) (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1391.json	Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1393.json	WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1400.json	Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1402.json	Cancer [Malignant Neoplasms] (Disorders) (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1403.json	Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)	active	2023-06	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1404.json	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)	active	2024-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1405.json	Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1407.json	Cancer [Malignant Neoplasms] (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1418.json	Alpha gal syndrome (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1420.json	Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1422.json	Ptosis of Eyelid [Unspecified Cause] (SNOMED)	active	2024-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1423.json	Ptosis of Eyelid [Unspecified Cause] (ICD10CM)	active	2024-06	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1424.json	Constipation [Unspecified Cause] (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1426.json	Intubation [Respiratory Tract] (Procedure) (SNOMED)	active	2023-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1430.json	Infant Botulism (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1446.json	Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1447.json	MRSA (Disorders (SNOMED)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1449.json	Staphylococcus aureus infection (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.145.json	Varicella (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1450.json	Staphylococcus aureus infection (Disorders) (ICD10CM)	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1452.json	MRSA (Tests by Culture and Identification Method)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1453.json	MRSA (Tests for Methicillin Resistance Gene)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1454.json	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1458.json	Tests for Cefoxitin Susceptibility [OrdQn]	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1459.json	Organisms (Tests in Blood by Culture and Identification)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1460.json	Bacteria (Tests in Blood by Culture and Identification Method)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1461.json	Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)	active	2024-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1462.json	Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1463.json	VRE (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1464.json	VRE (Organism or Substance in Lab Results)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1465.json	VRE (Tests by Culture and Identification Method)	active	2023-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1466.json	Enterococcus species (Tests by Culture and Identification Method)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1468.json	Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1469.json	Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1470.json	Enterococcus species (Organism or Substance in Lab Results)	active	2023-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1471.json	Amebiasis (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1473.json	Amebiasis (Disorders) (ICD10CM)	active	2023-01	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1476.json	Amebiasis (Tests for Entamoeba histolytica Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1482.json	Norovirus (Tests for Norovirus Nucleic Acid)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1485.json	Norovirus (Organism or Substance in Lab Results)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1487.json	Clostridioides difficile infection (Disorders) (SNOMED)	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1491.json	C. diff infection (Tests for C diff Toxin Nucleic Acid)	active	2024-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1492.json	C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)	active	2025-02	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1505.json	Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED)	active	2024-01	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113762.1.4.1146.1507.json	Arsenic Exposure and Toxicity (Disorders) (SNOMED)	active	2023-01	us	sct